GUY, David et al. Metastatic progression following multimodal therapy for unfavorable-risk prostate cancer. Canadian Urological Association Journal, [S. l.], v. 16, n. 4, p. E220–6, 2021. DOI: 10.5489/cuaj.7525. Disponível em: https://cuaj.ca/index.php/journal/article/view/7525. Acesso em: 26 apr. 2026.